Biotech · Private company
Tiziana Life Sciences LTD
Track this companyFree. Adds Tiziana Life Sciences LTD to your Dealase workspace and tells you when its record changes.
Clinical trials95 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- ForalumabPhase 2 · Secondary Progressive Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Foralumab NasalPhase 2 · Multiple System AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- Foralumab NasalPhase 2 · ALS (Amyotrophic Lateral Sclerosis)ClinicalTrials.gov · fetched Nov 12, 2026
- Foralumab TZLS-401 100 µgPhase 2 · Non-Active Secondary Progressive Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Milciclib MaleatePhase 2 · Thymic CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Milciclib MaleatePhase 2 · Malignant ThymomaClinicalTrials.gov · fetched Nov 12, 2026
- Foralumab NasalPhase 1 · SafetyClinicalTrials.gov · fetched Nov 12, 2026
- Foralumab TZLS-401 50 µgNon-Active Secondary Progressive Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal ForalumabPHASE2 · ENROLLING_BY_INVITATION · started Sep 23, 2026ClinicalTrials.gov NCT07688239 · fetched Nov 12, 2026
- Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's DiseasePHASE2 · RECRUITING · started Sep 16, 2025ClinicalTrials.gov NCT06489548 · fetched Nov 12, 2026
- A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)PHASE2 · RECRUITING · started May 19, 2025ClinicalTrials.gov NCT06868628 · fetched Nov 12, 2026
- Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisPHASE2 · RECRUITING · started Mar 4, 2025ClinicalTrials.gov NCT06890923 · fetched Nov 12, 2026
- A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 15, 2023ClinicalTrials.gov NCT06292923 · fetched Nov 12, 2026
- Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human VolunteersPHASE1 · COMPLETED · started Nov 12, 2018ClinicalTrials.gov NCT06879067 · fetched Nov 12, 2026
- Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of ChemotherapyPHASE2 · TERMINATED · started Feb 2, 2011ClinicalTrials.gov NCT01301391 · fetched Nov 12, 2026
- Phase II Study Of Oral PHA-848125AC In Patients With Thymic CarcinomaPHASE2 · TERMINATED · started Feb 22, 2010ClinicalTrials.gov NCT01011439 · fetched Nov 12, 2026
- Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS PatientsAVAILABLEClinicalTrials.gov NCT06802328 · fetched Nov 12, 2026